ESC & iPSC News Volume 17.42 | Nov 02 2022

    0
    89








    2022-11-02 | ESC & iPSC 17.42


    ESC & iPSC News by STEMCELL Technologies
    Vol. 17.42 – 2 November, 2022
    TOP STORY

    Intermediate Cells of In Vitro Cellular Reprogramming and In Vivo Tissue Regeneration Require Desmoplakin

    Researchers identified the cytoskeletal linker protein desmoplakin as a common factor mediating both in vitro reprogramming and in vivo regeneration.
    [Science Advances]

    Full Article
    Register for Stem Cells: Advances in the Application of Stem Cells and Their Role In Vivo.
    PUBLICATIONSRanked by the impact factor of the journal

    A Satellite DNA Array Barcodes Chromosome 7 and Regulates Totipotency via ZFP819

    To test whether KRAB-zinc finger proteins could regulate cell fate by using ZFP819, investigators found that depleting ZFP819 in mESCs caused them to transition to a 2-cell-like state, whereby the ZP3AR array switched from a poised to an active enhancer state.
    [Science Advances]

    Full Article

    Transient Inhibition of p53 Enhances Prime Editing and Cytosine Base-Editing Efficiencies in Human Pluripotent Stem Cells

    Scientists reported that co-delivery of p53DD, a dominant negative fragment of p53, could greatly enhance prime editing (PE) and cytosine base editing efficiencies in generating precise mutations in hPSCs. They further applied PE3 enzyme in combination with p53DD to efficiently create multiple isogenic hPSC lines.
    [Nature Communications]

    Full Article

    Stabilization of Cell-Cell Adhesions Prevents Symmetry Breaking and Locks In Pluripotency in 3D Gastruloids

    RNA sequencing and lineage fate analysis revealed that budesonide prevented ESC aggregates to break symmetry by counteracting exit from pluripotency and modifying the expression of a large set of genes associated with cell migration, A-P axis formation, and WNT signaling.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Comparative Analysis of Porcine iPSCs Derived from Sertoli Cells and Fibroblasts

    Researchers established a fast and efficient induction system of porcine iPSCs from porcine Sertoli cells via forced expression of pig Yamanaka factors.
    [Journal of Cellular Physiology]

    Abstract

    Identification of Marker Genes to Monitor Residual iPSCs in iPSC-Derived Products

    The authors focused on identifying markers for iPSC impurities in iPSC-derived cardiomyocytes and validated the selected genes by reverse transcription quantitative polymerase chain reaction.
    [Cytotherapy]

    Abstract

    Nucleosome Breathing Facilitates Cooperative Binding of Pluripotency Factors Sox2 and Oct4 to DNA

    Using a novel coarse-grained model and molecular dynamics simulations, scientists probed the association of Sox2 and Oct4 proteins that showed clustered binding at the entry-exit region of a nucleosome.
    [Biophysical Journal]

    Abstract

    Therapeutic Function of a Novel Rat Induced Pluripotent Stem Cell Line in a 6-OHDA-Induced Rat Model of Parkinson’s Disease

    Green fluorescent protein+/iPS‑like colony generation was facilitated by the small molecules CHIR99021 and RepSox during lentivirus‑mediated reprogramming of six transcription factors in rat embryonic fibroblasts.
    [International Journal of Molecular Medicine]

    Abstract

    Embryonic Stem Cells Lacking DNA Methyltransferases Differentiate into Neural Stem Cells That Are Defective in Self-Renewal

    Investigators used three types of DNA methyltransferase (Dnmt) knockout (KO) ESCs, including Dnmt1 KO, Dnmt3a/3b double KO, and Dnmt1/3a/3b triple KO, to investigate the role of Dnmts in neural differentiation of ESCs.
    [International Journal of Stem Cells]

    Abstract
    Scientific resources to support your stem cell research. Learn More!
    REVIEWS

    Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development

    The authors review the state of the art of use of PSCs as a model for hematopoietic and leukemia development.
    [Stem Cells Translational Medicine]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    I Peace Partners with the California Institute for Regenerative Medicine [CIRM]

    I Peace, Inc. announced that the company has agreed to join the California Institute for Regenerative Medicine’s (CIRM) Industry Resource Partner Program to pave way for the provision of Good Manufacturing Practice iPSCs for various research programs funded by CIRM.
    [I Peace, Inc. (Cision US Inc.)]

    Press Release

    Cedars-Sinai Awarded $8 Million to Launch New Stem Cell Clinic

    Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies.
    [Cedars-Sinai]

    Press Release
    FEATURED EVENT

    ESMO Targeted Anticancer Therapies Congress 2023

    March 6 – 8, 2023
    Paris, France

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Regenerative Medicine

    National University of Ireland Galway – Galway, Ireland

    Senior Research Scientist – Pancreatic Organoid Research

    Max Delbrück Center for Molecular Medicine – Berlin, Germany

    Director – Division of Preclinical Innovation

    NIH National Center for Advancing Translational Sciences – Rockville, Maryland, United States

    Postdoctoral Fellow – Epigenetics

    Cold Spring Harbor Laboratory – New York, New York, United States

    Research Associate – iPSC technology

    DaCapo Brainscience – Cambridge, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter